Merck KGaA
Capitalisation boursière
$19.1B
Rang mondial
#331
Sommet historique
$63.3B
2026-12-31
Croissance totale
+0%
depuis 2026
Market Cap Context
- Larger than 10% of the 367 companies we track (globally).
- Equivalent to 0.4% of Germany's GDP (2025 data).
- Just above: #330 General Mills, Inc. ($20.4B)
- Just below: #332 Wipro Limited ($18.9B)
- Best year: 2021 (+63%). Worst year: 2002 (-37%).
Merck KGaA Financial Breakdown (FY 2025)
Source: Yahoo Finance — MRK.DE annual filings (2025) (converted from EUR at 0.93) →$22.7B revenue · $3.9B operating income · $2.8B net income
- ●Operating margin: 17.3% on $22.7B in revenue.
- ●R&D is 11.4% of revenue ($2.6B).
- ●Net income margin: 12.4% — $2.8B in profit.
- ●Free cash flow: $2.1B (9.4% of revenue).
Cost / Operating Expenses
Total operating expenses $18.8B
Total
$17.9B
Capital Expenditures
$2.1B
This fiscal year (near-total AI infrastructure buildout)
Free Cash Flow
$2.1B
Trailing twelve months
Figures rounded from the annual SEC filing. Unaudited. For informational purposes only, not investment advice.
À propos de Merck KGaA
The Merck Group, branded and commonly known as Merck, is a German multinational science and technology company headquartered in Darmstadt, with about 60,000 employees and a presence in 66 countries. The group includes around 250 companies; the main company is Merck KGaA in Germany. The company is divided into three business lines: Healthcare, Life Sciences and Electronics. Merck was founded in 1668 and is the world's oldest operating chemical and pharmaceutical company, as well as one of the largest pharmaceutical companies globally.
Historique de la capitalisation boursière de Merck KGaA (2026–2026)
Merck KGaA vs Sector Peers by Market Cap
Comparer Merck KGaA
Historique du classement
| Année | Capitalisation boursière | Rang | Variation sur un an |
|---|---|---|---|
| 2026 | $19.1B | #331(↑3) | +13.8% |
| 2025 | $16.8B | #334(↓8) | -10.7% |
| 2024 | $18.8B | #326 | -1.5% |
| 2023 | $19.1B | #326(↓28) | -19.2% |
| 2022 | $23.6B | #298(↓11) | -19.5% |
| 2021 | $29.3B | #287(↑29) | +63.3% |
| 2020 | $18.0B | #316(↓8) | +34.9% |
| 2019 | $13.3B | #308(↓15) | +18.6% |
| 2018 | $11.2B | #293(↓5) | +1.8% |
| 2017 | $11.0B | #288(↓29) | -8.5% |
| 2016 | $12.0B | #259(↓6) | +12.1% |
| 2015 | $10.7B | #253(↑7) | +15.3% |
| 2014 | $9.3B | #260(↑8) | +22.3% |
| 2013 | $7.6B | #268(↓12) | +32.4% |
| 2012 | $5.8B | #256(↓1) | +31.9% |
| 2011 | $4.4B | #255(↑13) | +31.3% |
| 2010 | $3.3B | #268(↓14) | -6.6% |
| 2009 | $3.6B | #254(↓27) | +3.3% |
| 2008 | $3.4B | #227(↑12) | -26.9% |
| 2007 | $4.7B | #239 | +15.4% |
| 2006 | $4.1B | #239(↓8) | +13.6% |
| 2005 | $3.6B | #231(↑1) | +40.7% |
| 2004 | $2.6B | #232(↑3) | +56.5% |
| 2003 | $1.6B | #235(↓5) | +36.0% |
| 2002 | $1.2B | #230(↓13) | -37.0% |
| 2001 | $1.9B | #217(↓22) | -9.8% |
| 2000 | $2.1B | #195(↓23) | +60.1% |
| 1999 | $1.3B | #172(↓23) | -22.5% |
| 1998 | $1.7B | #149 |
Autres entreprises du secteur Santé
FAQ
What is Merck KGaA's market cap?
Merck KGaA (MRK.DE) has a market capitalization of $19.1B, making it the #331 largest company in the world by market cap.
What was Merck KGaA's highest market cap?
Merck KGaA's all-time high market cap was $63.3B, reached in 2026-12-31. Its highest rank was #287 in 2021.
What sector is Merck KGaA in?
Merck KGaA is in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry. It is based in Germany.
How has Merck KGaA's market cap changed over time?
Merck KGaA has been tracked since 2026. Its market cap has grown by 0% from $19.1B in 2026 to $19.1B today.